Supernus Pharmaceuticals Inc (SUPN)

Exchange
NASDAQ
Symbol
SUPN
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of diseases of the central nervous system in the United States. The company is headquartered in Rockville, Maryland.
Country
USA

Stock price

At close: March 7, 2025

  • Open
    31.72
  • High
    32.30
  • Low
    31.48
  • Close
    32.07
  • Volume
    655,869

Financial ratios

Dec 31, 2024